Reproductive Health & Justice Department of Justice FOIA Request Seeks Information on Enforcement of Comstock Act Against Medication Abortion July 1, 2026 Rifan Muazin On June 24, 2026, a Freedom of Information Act (FOIA) request was formally submitted to the Department of Justice (DOJ), seeking detailed information and communications concerning any internal reviews or…
Reproductive Health & Justice FOIA Request Filed Seeking Transparency in FDA’s Mifepristone Study Procurement Process June 30, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been filed with the Food and Drug Administration (FDA) seeking comprehensive documentation related to the solicitation and contract award procedures for the…
Reproductive Health & Justice FOIA Request Filed for Transparency in FDA’s Mifepristone Study Procurement Process June 17, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on June 9, 2026, to the Food and Drug Administration (FDA) seeking detailed information concerning the solicitation and contract award processes…
Reproductive Health & Justice America First Global Health Strategy Under Scrutiny as FOIA Request Seeks Clarity on Health MOUs and Reproductive Health Conditions May 16, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request filed by an unnamed advocacy group on April 14, 2026, seeks to illuminate the intricacies of the "America First Global Health Strategy," with…
Reproductive Health & Justice FOIA Request Seeks Clarity on "America First Global Health Strategy" and Reproductive Health Conditions in International Agreements May 8, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been filed with the U.S. Department of State, seeking comprehensive records and communications pertaining to the "America First Global Health Strategy." The…
Reproductive Health & Justice FOIA Request Seeks Comprehensive Safety Data on Mifepristone from FDA April 24, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been formally submitted to the U.S. Food and Drug Administration (FDA), seeking a broad spectrum of safety data pertaining to mifepristone, a…
Reproductive Health & Justice FOIA Request Filed for Comprehensive Mifepristone Safety Data Amid Evolving Regulatory Scrutiny April 16, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on March 20, 2026, seeking a broad spectrum of safety data related to mifepristone, a medication widely used in medication abortion…
Reproductive Health & Justice FOIA Request Seeks Deeper Dive into Mifepristone Safety Data from FDA April 9, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been submitted to the U.S. Food and Drug Administration (FDA) seeking comprehensive safety data related to mifepristone, a medication used in medication…
Reproductive Health & Justice FDA Adverse Event Data FOIA April 1, 2026 Rifan Muazin The submission of a Freedom of Information Act (FOIA) request on March 20, 2026, seeking comprehensive safety data on mifepristone, marks a significant development in the ongoing scrutiny of this…
Reproductive Health & Justice FDA Adverse Event Data FOIA March 25, 2026 Rifan Muazin Advocacy Group Demands FDA Transparency on Mifepristone Safety Data Amidst Ongoing Legal Battles A prominent reproductive rights advocacy organization has formally requested detailed safety data pertaining to mifepristone, a medication…
